Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Clinical trial NCT05274815 · COMPLETED
Trial details
- NCT number
- NCT05274815
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2024-09-09
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.